These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18344734)

  • 1. Photo-onycholysis caused by olanzapine and aripiprazole.
    Gregoriou S; Karagiorga T; Stratigos A; Volonakis K; Kontochristopoulos G; Rigopoulos D
    J Clin Psychopharmacol; 2008 Apr; 28(2):219-20. PubMed ID: 18344734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole.
    Wolf J; Fiedler U
    J Clin Pharm Ther; 2007 Apr; 32(2):197-8. PubMed ID: 17381670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive effects of aripiprazole on metabolic profiles: comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs.
    Wang LJ; Ree SC; Huang YS; Hsiao CC; Chen CK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():260-6. PubMed ID: 23085073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cochrane for clinicians. Aripiprazole vs. other atypical antipsychotics for schizophrenia.
    Guirguis-Blake J
    Am Fam Physician; 2010 Jun; 81(11):1335-6. PubMed ID: 20521753
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.
    Koener B; Hermans E; Maloteaux JM; Jean-Jean A; Constant EL
    Am J Psychiatry; 2007 Sep; 164(9):1437-8. PubMed ID: 17728432
    [No Abstract]   [Full Text] [Related]  

  • 6. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
    Chen CH; Huang MC; Lu ML
    J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
    [No Abstract]   [Full Text] [Related]  

  • 7. Hiccups associated with switching from olanzapine to aripiprazole in a patient with paranoid schizophrenia.
    Hori H; Nakamura J
    Clin Neuropharmacol; 2014; 37(3):88-9. PubMed ID: 24824665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manic episode during treatment with aripiprazole.
    Padala PR; Wengel SP; Petty F
    Am J Psychiatry; 2007 Jan; 164(1):172-3. PubMed ID: 17202565
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
    J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expectations and developments in atypical antipsychotics].
    Praxis (Bern 1994); 2004 Aug; 93(35):1392. PubMed ID: 15468579
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder].
    De Schutter P; Bouckaert F; Peuskens J
    Tijdschr Psychiatr; 2011; 53(5):299-303. PubMed ID: 21538299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo.
    L'Italien GJ; Casey DE; Kan HJ; Carson WH; Marcus RN
    J Clin Psychiatry; 2007 Oct; 68(10):1510-6. PubMed ID: 17960964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aripiprazole: a new atypical antipsychotic drug].
    Fischer B; Davids E; Gastpar M
    Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis in a patient on aripiprazole with traumatic hip prosthesis luxation.
    Marzetti E; Bocchino L; Teramo S; Scudieri G; Aulisa AG
    J Neuropsychiatry Clin Neurosci; 2012; 24(4):E40-1. PubMed ID: 23224480
    [No Abstract]   [Full Text] [Related]  

  • 15. Aripiprazole-induced hyponatremia: a case report.
    Behere RV; Venkatasubramanian G; Naveen MN; Gangadhar BN
    J Clin Psychiatry; 2007 Apr; 68(4):640-1. PubMed ID: 17474829
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.
    Henderson DC; Fan X; Copeland PM; Sharma B; Borba CP; Boxill R; Freudenreich O; Cather C; Evins AE; Goff DC
    J Clin Psychopharmacol; 2009 Apr; 29(2):165-9. PubMed ID: 19512978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory restless legs syndrome likely caused by olanzapine.
    Khalid I; Rana L; Khalid TJ; Roehrs T
    J Clin Sleep Med; 2009 Feb; 5(1):68-9. PubMed ID: 19317385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.
    Meyer JM; Rosenblatt LC; Kim E; Baker RA; Whitehead R
    J Clin Psychiatry; 2009 Mar; 70(3):318-25. PubMed ID: 19192469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute dystonia associated with aripiprazole in a child.
    Singh MK; DelBello MP; Adler CM
    J Am Acad Child Adolesc Psychiatry; 2007 Mar; 46(3):306-307. PubMed ID: 17314714
    [No Abstract]   [Full Text] [Related]  

  • 20. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.
    Thone J
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):481-2. PubMed ID: 18070865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.